Darling Ingredients Inc. Common Stock vs Definium Therapeutics Inc. Common Shares — how do they compare? Darling Ingredients Inc. Common Stock trades at $62.25 (market cap $9.82B), while Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B). The key difference: Darling Ingredients Inc. Common Stock is far larger — about 2.1× Definium Therapeutics Inc. Common Shares's market cap, and Darling Ingredients Inc. Common Stock is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Darling Ingredients Inc. Common Stock for 0 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| DAR | DFTX | |
|---|---|---|
Market Cap | $9.82B | $4.59B |
Volume | 2,815,184 | 2,103,937 |
Sector | Consumer Staples | Health |
52-Week High | $68.34 | $48.45 |
52-Week Low | $29.91 | $10.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.83B | $3.55B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Darling Ingredients collects and processes used cooking oil, animal by-products, and food waste. It produces ingredients and renewable fuel feedstocks from these materials.
Read more on DAR →Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →